BBNX

Beta Bionics (BBNX)

About Beta Bionics (BBNX)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Details

Daily high

$11.42

Daily low

$10.85

Price at open

$11.00

52 Week High

$32.71

52 Week Low

$8.89

Market cap

498.9M

Dividend yield

0.00%

Volume

579,963

Avg. volume

1.1M

P/E ratio

-6.69

Beta Bionics News